Gujarat Themis Biosyn Share Price
Small Cap | Pharmaceuticals and health care | BSE: 506879
₹244.40 -0.05 (-0.02 %)
Last Updated: 21 Feb 2025 04:01 PM
Overview
Open (₹) 244.45
High (₹) 253.40
Low (₹) 242.00
Prev. Close (₹) 244.45
Volume 41,355
VWAP (₹) 246.79
ROCE (%) 38.82
Industry P/E 43.99
TTM P/E 50.60
P/B Ratio 8.82
Market Cap (₹) Cr.2,663.11
Dividend Yield (%)0.41
EPS (₹) 8.14
ROE29.37%
Sales Growth (%) 14
Profit Growth (%)2.06
Day Range
253.40253.40
52 Week Range
192.35390.00
Historical Returns
Returns (6M)
-36.35 %
Returns (1Y)
2.63 %
Returns (3Y)
402.36 %
Returns (5Y)
1625.99 %
Returns (6M)
-36.35 %
Returns (1Y)
2.63 %
Returns (3Y)
402.36 %
Returns (5Y)
1625.99 %
SWOT Analysis
Technicals
Technical Rating
RSI 52.95
MFI 43.34
ATR 25.31
Commodity Channel Index -69.74
ROC125 -32.75
ROC21 -22.58
Williams %R -53.75
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 251.20 | 258.00 | 262.60 | 246.60 | 239.80 | 235.20 | 228.40 |
Week Ago | 270.54 | 291.92 | 314.84 | 247.62 | 226.24 | 203.32 | 181.94 |
Month Ago | 338.55 | 353.25 | 361.50 | 330.30 | 315.60 | 307.35 | 292.65 |
EMA & SMA
244.40
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 234.22
9 Day 249.82
10 Day 253.85
12 Day 261.79
14 Day 262.80
20 Day 271.59
26 Day 285.50
50 Day 299.14
100 Day 311.35
200 Day 315.02
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
PHARMACEUTICAL BUSINESS GROUP I LTD | bulk | Sell | 27 Dec, 2023 | ₹215.35 | 30,00,000 | BSE |
MC JAIN INFOSERVICES PRIVATE LIMITED | bulk | Buy | 27 Dec, 2023 | ₹215.00 | 4,90,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
29 Dec, 2023 | Pharmaceutical Business Group [India] Ltd | Disposal | ₹215.1283753333333333333333333 | 30,00,000 | BSE |
28 Sept, 2023 | Mrs.Avantika Vijay Agarwal | Acquisition | ₹913.8616666666666666666666667 | 5,400 | BSE |
18 Dec, 2021 | Mrs.Avantika Vijay Agarwal | Disposal | ₹500.7135529157667386609071274 | 3,704 | BSE |
15 Dec, 2021 | Ms. Avantika Vijay Agarwal | Disposal | ₹501.4878048780487804878048780 | 656 | BSE |
15 Dec, 2021 | Ms. Avantika Vijay Agarwal | Disposal | ₹503.9720992028343666961913198 | 9,032 | BSE |
20 Sept, 2021 | Pharmaceutical Business Group India Limited | Acquisition | ₹150.00 | 38,50,000 | BSE |
20 Sept, 2021 | Yuhan Corporation | Disposal | ₹150.00 | 38,50,000 | BSE |
17 Jun, 2021 | Mr.Rajneesh Anand | Acquisition | ₹295.208 | 5,250 | BSE |
17 Jun, 2021 | Mr.Rajneesh Anand | Acquisition | ₹286.5148571428571428571428571 | 1,750 | BSE |
12 Mar, 2021 | Ms. Indu Vijay Agarwal | Disposal | ₹214.7346 | 5,000 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
14 May, 2024 | Bonus issue in the ratio of 1:2 of Re. 1/-. | 09 Aug, 2024 | 09 Aug, 2024 |
14 May, 2024 | Rs.0.2500 per share(25%)Final Dividend | 15 Jul, 2024 | 01 Jan, 1970 |
12 Feb, 2024 | Rs.0.7500 per share(75%)Interim Dividend | 22 Feb, 2024 | 22 Feb, 2024 |
15 May, 2023 | Rs.1.0000 per share(20%)Final Dividend | 01 Sept, 2023 | 01 Jan, 1970 |
13 May, 2023 | Stock split from Rs. 5/- to Re. 1/-. | 10 Oct, 2023 | 10 Oct, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
21 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attached Investor presentation for detailed information. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
02 Jan, 2025 | BSE India | Please refer to the attachment. |
18 Nov, 2024 | BSE India | Please refer attached annexure for further information |
18 Nov, 2024 | BSE India | Please refer to the attachment. |
07 Nov, 2024 | BSE India | Please refer to the attachment |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 11 Feb, 2025 | 14 Feb, 2025 |
Quarterly Results | -- | 22 Oct, 2024 | 25 Oct, 2024 |
Quarterly Results | -- | 18 Jul, 2024 | 26 Jul, 2024 |
Audited Results, Dividend & Bonus issue | -- | 07 May, 2024 | 14 May, 2024 |
Quarterly Results & Interim Dividend | -- | 08 Feb, 2024 | 10 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 04 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 12 Aug, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
Audited Results, F. Dividend & Stock Split | -- | 05 May, 2023 | 13 May, 2023 |
Quarterly Results | -- | 30 Jan, 2023 | 03 Feb, 2023 |
Share Holding Pattern
Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
---|
About Gujarat Themis Biosyn
Gujarat Themis Biosyn is a Public Limited Listed company incorporated on 11/12/1981 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1981PLC004878 and registration number is 004878. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 169.82 Cr. and Equity Capital is Rs. 7.26 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Joint Sector Holding
Founded
1981
Managing Director
-- --
NSE Symbol
--
Gujarat Themis Biosyn Management
Name | Designation |
---|---|
Dr. Dinesh S Patel | Chairman & Non-Exe.Director |
Dr. Sachin D Patel | Promoter Non-Exe.Director |
Mr. Vijay Agarwal | Ind. Non-Executive Director |
Dr. Vikram D Sanghvi | Ind. Non-Executive Director |
Mr. Siddharth Y Kusumgar | Ind. Non-Executive Director |
Mrs. Kirandeep Kaur Madan | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,643.75 ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Gujarat Themis Biosyn
What is the share price of Gujarat Themis Biosyn?
The share price of Gujarat Themis Biosyn on 21 Feb, 2025 is ₹ 244.40.
What is 52W high and 52W low share price of Gujarat Themis Biosyn?
The highest and lowest 52W share prices of Gujarat Themis Biosyn are ₹ 390.000 and ₹ 146.740
What is the market cap of Gujarat Themis Biosyn?
The market capitalization of Gujarat Themis Biosyn as of 21 Feb, 2025 is ₹ 2,663.11 Crores
What is the P/E ratio of Gujarat Themis Biosyn?
The current P/E ratio of Gujarat Themis Biosyn as of 21 Feb, 2025 is 43.99
What is the PB ratio of Gujarat Themis Biosyn?
The PB ratio of Gujarat Themis Biosyn as of 21 Feb, 2025 is 8.82
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)